Pharmaceuticals & Life Sciences · Real-World Evidence & Outcomes Research
Health Economics Modeling & Budget Impact Analysis
Trajectories describe the observable direction of human effort — not a prediction about specific roles, headcount, or individual careers.
What You Do Today
Build economic models — cost-effectiveness analyses, budget impact models, and Markov models — that quantify the value of therapies for health technology assessments, payer submissions, and formulary reviews.
AI Technologies
Roles Involved
How It Works
AI automates the construction of health economic models by extracting parameters from published literature and clinical trial data. Automated sensitivity analyses explore thousands of parameter combinations to identify key value drivers. Scenario simulation predicts model outcomes under different clinical and economic assumptions.
What Changes
Model development and sensitivity analysis cycles compress. AI identifies which parameters most influence the cost-effectiveness conclusion, focusing analyst effort on the assumptions that matter most.
What Stays the Same
Selecting the appropriate modeling framework, making assumptions about natural disease progression, and presenting economic arguments to HTA bodies and payer committees require health economics expertise and persuasive communication.
Evidence & Sources
- •NICE technology appraisal methods guide
- •ICER value assessment framework
Sources listed are directional references, not formal citations. Verify against primary sources before using in business cases or presentations.
Last reviewed: March 2026
What To Do Next
This section won't tell you what your numbers should be. It will show you how to find them yourself. Every instruction below produces a real, verifiable result in your organization. No benchmarks, no projections — just the steps to build your own evidence.
Establish Your Baseline
Know where you are before you move
Before adopting AI tools for health economics modeling & budget impact analysis, document your current state in real-world evidence & outcomes research.
Without a baseline, you can't tell whether AI actually improved health economics modeling & budget impact analysis or just changed who does it.
Define Your Measures
What to track and how to calculate it
report delivery time
How to calculate
Measure report delivery time for health economics modeling & budget impact analysis before and after AI adoption. Pull from your data warehouse.
Why it matters
This is the most direct indicator of whether AI is adding value to real-world evidence & outcomes research.
self-service adoption rate
How to calculate
Track self-service adoption rate using the same methodology you use today. Don't change how you measure just because you changed how you work.
Why it matters
Speed without quality is just faster mistakes. Measure both together.
Start These Conversations
Who to talk to and what to ask
VP Data or Chief Data Officer
“What's our plan for AI in real-world evidence & outcomes research? Are we piloting, planning, or waiting?”
This tells you whether to experiment quietly or push for formal investment in health economics modeling & budget impact analysis.
your data warehouse administrator or vendor
“What AI capabilities exist in our current data warehouse that we're not using? Most platforms are adding AI features faster than teams adopt them.”
The cheapest AI adoption is the features already included in your existing license.
a practitioner in real-world evidence & outcomes research at another organization
“Have you deployed AI for health economics modeling & budget impact analysis? What worked, what didn't, and what would you do differently?”
Peer experience is more useful than vendor demos. Find someone who has actually done this.
Check Your Prerequisites
Confirm readiness before you invest
Check items as you confirm them.